A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma. (Q46033801)
Jump to navigation
Jump to search
scientific article published in July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma. |
scientific article published in July 2009 |
Statements
1 reference
A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma. (English)
1 reference
Philippe Beuzeboc
1 reference
Christian Wülfing
1 reference
Jean-Pascal H Machiels
1 reference
Dirk J Richel
1 reference
Uwe Treiber
1 reference
Marco R De Groot
1 reference
Roma Parikh
1 reference
Frank Pétavy
1 reference
Iman A El-Hariry
1 reference
1 July 2009
1 reference
1 reference
115
1 reference
2881-2890
1 reference
13
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference